Current trends in QSAR on NO donors and inhibitors of nitric oxide synthase (NOS)

被引:11
作者
Kontogiorgis, CA [1 ]
Hadjipavlou-Litina, D [1 ]
机构
[1] Aristotle Univ Thessaloniki, Sch Pharm, Dept Pharmaceut Chem, Thessaloniki 54124, Greece
关键词
QSAR; NO donors; NOS inhibitors; electronic factors; steric factors; lipophilicity;
D O I
10.1002/med.10012
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This article evaluates the quantitative structure-activity relationships (QSAR) of nitric oxide (NO) radical donors and nitric oxide synthases (NOS) inhibitors, using the C-QSAR program of Biobyte. Furoxans, triazines, amidoximes, tetrazoles, imidazoles and N-omega-2-nilro-arylamino acid analogues were included in this survey. In nine out of seventeen cases, the clog P plays a significant part in the QSAR of the NO radical donors and of the NOS inhibition, Many of the compounds must be interacting with a hydrophobic space in a non-specific way. In some cases molecular refractivity CMR/MR as well as sterimol parameters (B-1 and L) are important, Electronic effects, with the exception of the Hammett's constant sigma and the Swain-Lupton parameter F, are not found to govern the biological activity. Stereochemical and electronic features are also found to be important. Indicator variables were used after the best model was found to account for the usual structural features. (C) 2002 Wiley Periodicals, Inc.
引用
收藏
页码:385 / 418
页数:34
相关论文
共 94 条
  • [81] SEVERINA IS, 1993, BIOCHEM MOL BIOL INT, V30, P357
  • [82] SILIPO C, 1990, COMPREHENSIVE MED CH, V4, P153
  • [83] PHOTOSENSITIZED DECOMPOSITION OF S-NITROSOTHIOLS AND 2-METHYL-2-NITROSOPROPANE POSSIBLE USE FOR SITE-DIRECTED NITRIC-OXIDE PRODUCTION
    SINGH, RJ
    HOGG, N
    JOSEPH, J
    KALYANARAMAN, B
    [J]. FEBS LETTERS, 1995, 360 (01) : 47 - 51
  • [84] SMITH PAS, 1996, OPEN CHAIN NITROGEN, V2, P29
  • [85] Water soluble furoxan derivatives as NO prodrugs
    Sorba, G
    Medana, C
    Fruttero, R
    Cena, C
    DiStilo, A
    Galli, U
    Gasco, A
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (04) : 463 - 469
  • [86] TAYCH MA, 1989, J BIOL CHEM, V264, P19654
  • [87] KINETICS OF NITRIC-OXIDE LIBERATION BY 3,4-DIHYDRO-1,2-DIAZETE 1,2-DIOXIDES AND THEIR VASODILATORY PROPERTIES IN-VITRO AND IN-VIVO
    UTEPBERGENOV, DI
    KHRAMTSOV, VV
    VLASSENKO, LP
    MARKEL, AL
    MAZHUKIN, DG
    TIKHONOV, AY
    VOLODARSKY, LB
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 214 (03) : 1023 - 1032
  • [88] Verloop A, 1976, DRUG DESIGN, V7, P165, DOI DOI 10.1016/B978-0-12-060307-7.50010-9
  • [89] WOLFF DJ, 1993, J BIOL CHEM, V268, P9430
  • [90] WOLFF DJ, 1993, J BIOL CHEM, V268, P9425